Order Article Reprints

Akil H, Quintana M, Raymond JH, Billoux T, Benboubker V, Besse S, Auzeloux P, Delmas V, Petit V, Larue L, et al. Efficacy of Targeted Radionuclide Therapy Using [¹³¹I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant Melanoma. Cancers. 2021; 13(6):1421. https://doi.org/10.3390/cancers13061421

Akil, Hussein, Mercedes Quintana, Jérémy H. Raymond, Tommy Billoux, Valentin Benboubker, Sophie Besse, Philippe Auzeloux, Véronique Delmas, Valérie Petit, Lionel Larue, and et al. 2021. "Efficacy of Targeted Radionuclide Therapy Using [¹³¹I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant Melanoma" Cancers 13, no. 6: 1421. https://doi.org/10.3390/cancers13061421

Akil, H., Quintana, M., Raymond, J. H., Billoux, T., Benboubker, V., Besse, S., Auzeloux, P., Delmas, V., Petit, V., Larue, L., D’Incan, M., Degoul, F., & Rouanet, J. (2021). Efficacy of Targeted Radionuclide Therapy Using [¹³¹I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant Melanoma. Cancers, 13(6), 1421. https://doi.org/10.3390/cancers13061421